Asia accounted for nearly 70% of the global incidence of DLBCL in 2020, with Mainland China, India, and Japan contributing to a third of all DLBCL cases worldwide.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more